Global Orphan Drugs Market Research Report - Forecast to 2022

1. Market Research Future Orphan Drugs Market by Value, Revenue, Segments, Mega trends, Prominent Players and Outlook to 2023 Orphan Drugs Market - Scenario Orphan drugs are generally used for treating rare disorders and diseases that affect a small percentage of the population. There are approximately 30 million in Europe, 30 million people in the US, and 350 million people worldwide who suffer from 7,000 types of rare diseases. Disorders among which four-fifths of the rare diseases are genetic and 50 % of the crowd affected being children. Only 5 % of the rare diseases had approved drug treatment with 326 new drugs being approved by FDA and brought to the market.waste, particularly of the electronic form as hospitals often update their equipment. Request Sample Copy at https://www.marketresearchfuture.com/sample_request/2312 Players Covered: The key players operating the market for orphan drugs are Alexion Pharmaceuticals Inc., Bayer AG, Sanofi, Celgene Corporation, Novartis AG, Biogen Idec Limited, Hoffmann- La Roche, Takeda Pharmaceuticals Company Limited, Bristol-Myers Squibb, Vertex Pharmaceuticals Inc. Johnson & Johnson, and others. Orphan Drugs Market – Segments Globally, the market for orphan drugs has been segmented on the basis of application, pharmacological class, source, technology, and region. The market has been segmented into enzyme replacement, protein replacement, and gene chromosome expression based on pharmacological class. The market has been segmented into oncology, blood-related disorders, neurology, nephrology, and infectious diseases based on applications. Among these, oncology is predicted to dominate the market owing to the increasing drug approvals for treating rare cancers. Regional Wise Analysis: Geographically, the market for orphan drugs has been spanned across regions such as North America, Europe, Asia Pacific, Middle East and Africa. North America has been estimated to hold the largest market share owing to well- established healthcare infrastructure, favorable regulations for drug approval for rare diseases, initiatives by non-governmental and governmental agencies to increase awareness related to use of orphan drugs, and drug exclusivity status received by orphan drugs.

2. Market Research Future Moreover, US contributes substantially to the market which calls for strong R&D for development of orphan drugs. Browse Complete Report at https://www.marketresearchfuture.com/reports/orphan- drugs-market-2312 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com